{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:37:32Z","timestamp":1770493052569,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ecl.2025.02.006","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:51:09Z","timestamp":1770411069000},"page":"119-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adrenal Emergencies"],"prefix":"10.1016","volume":"55","author":[{"given":"Rachel E.","family":"Bridwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"April","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2025.02.006_bib1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"Schmieder","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2025.02.006_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary Aldosteronism: Practical Approach to Diagnosis and Management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2025.02.006_bib3","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2215\/CJN.03150509","article-title":"Cardiorenal syndrome in acute decompensated heart failure","volume":"4","author":"Sarraf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ecl.2025.02.006_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1055\/s-0035-1565124","article-title":"Cardiovascular Risk in Primary Hyperaldosteronism","volume":"47","author":"Prejbisz","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2025.02.006_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/2359-3997000000274","article-title":"Diagnosis and management of primary aldosteronism","volume":"61","author":"Vilela","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1172-5-9","article-title":"Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism","volume":"5","author":"Amar","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ecl.2025.02.006_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2025.02.006_bib8","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/jch.14558","article-title":"Who should be screened for primary aldosteronism? A comprehensive review of current evidence","volume":"24","author":"Huang","year":"2022","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.ecl.2025.02.006_bib10","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib11","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.ecl.2025.02.006_bib12","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1210\/jc.2010-2137","article-title":"Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study","volume":"96","author":"Kumari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12902-022-01135-y","article-title":"The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review","volume":"22","author":"Manosroi","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ecl.2025.02.006_bib14","first-page":"79","article-title":"Neuroblastoma accompanied by hyperaldosteronism","volume":"3","author":"Gulleroglu","year":"2014","journal-title":"J Renal Inj Prev"},{"key":"10.1016\/j.ecl.2025.02.006_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.24953\/turkjped.2021.4697","article-title":"Phenotypic and genotypic characteristics of children with Bartter syndrome","volume":"64","author":"G\u00fcven","year":"2022","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.ecl.2025.02.006_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5662\/wjm.v5.i2.55","article-title":"Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations","volume":"5","author":"Al Shibli","year":"2015","journal-title":"World J Methodol"},{"key":"10.1016\/j.ecl.2025.02.006_bib17","first-page":"1029","article-title":"The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications","volume":"39","author":"Seccia","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2025.02.006_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40292-018-0288-6","article-title":"Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor","volume":"25","author":"Grasso","year":"2018","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.ecl.2025.02.006_bib19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients","volume":"51","author":"Rossi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2025.02.006_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2025.02.006_bib21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ecl.2025.02.006_bib22","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/S0149-2918(03)80282-5","article-title":"Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension","volume":"25","author":"Burgess","year":"2003","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.ecl.2025.02.006_bib23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.ecl.2025.02.006_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2025.02.006_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ajem.2004.12.001","article-title":"Multiple organ failure as initial presentation of pheochromytoma","volume":"23","author":"Herbland","year":"2005","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ecl.2006.09.014","article-title":"Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma","volume":"35","author":"Brouwers","year":"2006","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.ecl.2025.02.006_bib27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","article-title":"Pheochromocytoma: the expanding genetic differential diagnosis","volume":"95","author":"Bryant","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ecl.2025.02.006_bib28","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","article-title":"A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1651-2227.1992.tb12213.x","article-title":"A single pediatric center experience with 1025 children with hypertension","volume":"81","author":"Wyszy\u0144ska","year":"1992","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ecl.2025.02.006_bib31","doi-asserted-by":"crossref","first-page":"1021420","DOI":"10.3389\/fendo.2022.1021420","article-title":"Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology","volume":"13","author":"Constantinescu","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ecl.2025.02.006_bib32","doi-asserted-by":"crossref","first-page":"922112","DOI":"10.3389\/fsurg.2022.922112","article-title":"Unusually large paraganglioma complicated with successive catecholamine crises: A case report and review of the literature","volume":"9","author":"Huang","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.ecl.2025.02.006_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archsurg.1988.01400320042007","article-title":"Pheochromocytoma multisystem crisis. A surgical emergency","volume":"123","author":"Newell","year":"1988","journal-title":"Arch Surg"},{"key":"10.1016\/j.ecl.2025.02.006_bib34","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archinte.1992.00400180121020","article-title":"Fever in pheochromocytoma","volume":"152","author":"Gordon","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2005.10.046","article-title":"Pheochromocytoma multisystem crisis","volume":"67","author":"Moran","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.ecl.2025.02.006_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.mej.0000134729.95226.e7","article-title":"The paradox of hypotension and pheochromocytoma: a case report","volume":"11","author":"De Wilde","year":"2004","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib37","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1053\/ajkd.2002.33414","article-title":"Pheochromocytoma multisystem crisis in a patient with multiple endocrine neoplasia type IIB and pyelonephritis","volume":"39","author":"Caputo","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ecl.2025.02.006_bib38","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/ndt\/16.10.2100","article-title":"Hypertension due to phaeochromocytoma--an unusual cause of multiorgan failure","volume":"16","author":"Kolhe","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ecl.2025.02.006_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13054-019-2706-0","article-title":"Association between hydroxocobalamin administration and acute kidney injury after smoke inhalation: a multicenter retrospective study","volume":"23","author":"D\u00e9pret","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.ecl.2025.02.006_bib40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0735-6757(94)90245-3","article-title":"Imipramine-provoked paradoxical pheochromocytoma crisis: a case of cardiogenic shock","volume":"12","author":"Ferguson","year":"1994","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib41","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/adc.53.8.676","article-title":"Diagnosis of phaeochromocytoma after ingestion of imipramine","volume":"53","author":"Mok","year":"1978","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ecl.2025.02.006_bib42","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/ndt\/16.5.1069","article-title":"Nasty shock after an anti-emetic","volume":"16","author":"Maxwell","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ecl.2025.02.006_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2018.03.009","article-title":"Metoclopramide induced pheochromocytoma crisis","volume":"36","author":"Leonard","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1253\/jcj.64.785","article-title":"Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma","volume":"64","author":"Takagi","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ecl.2025.02.006_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0735-6757(89)90084-3","article-title":"Pheochromocytoma presenting as shock","volume":"7","author":"Bergland","year":"1989","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0310057X0002800314","article-title":"Acute heart failure in the parturient--do not forget phaeochromocytoma","volume":"28","author":"Gill","year":"2000","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ecl.2025.02.006_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/pgmj.60.700.111","article-title":"Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction)","volume":"60","author":"Cohen","year":"1984","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0167-5273(91)90307-B","article-title":"Pheochromocytoma with asymmetric septal hypertrophy and Wolff-Parkinson-White syndrome","volume":"32","author":"G\u00fcrlek","year":"1991","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ecl.2025.02.006_bib49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-8703(92)90954-T","article-title":"QT prolongation with torsade de pointes in pheochromocytoma","volume":"124","author":"Shimizu","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2025.02.006_bib50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0002-9610(67)90419-9","article-title":"Cardiac arrhythmias and cardiomyopathy associated with pheochromocytomas. Report of three cases","volume":"114","author":"Sode","year":"1967","journal-title":"Am J Surg"},{"key":"10.1016\/j.ecl.2025.02.006_bib51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0002-8703(68)90235-4","article-title":"Reflex bradycardia and nodal escape rhythm in pheochromocytoma","volume":"76","author":"Forde","year":"1968","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2025.02.006_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1253\/jcj.57.84","article-title":"A case of pheochromocytoma complicated with acute renal failure and cardiomyopathy","volume":"57","author":"Hamada","year":"1993","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ecl.2025.02.006_bib53","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/000331978503601008","article-title":"Uncommon presentation of pheochromocytoma: case studies","volume":"36","author":"Grossman","year":"1985","journal-title":"Angiology"},{"key":"10.1016\/j.ecl.2025.02.006_bib54","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-140-10-200405180-00033","article-title":"Epinephrine-secreting pheochromocytoma presenting with cardiogenic shock and profound hypocalcemia","volume":"140","author":"Olson","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib55","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/archinte.1993.00410170153018","article-title":"Pheochromocytoma as a cause of blue toes","volume":"153","author":"Tack","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib56","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/07357907.2021.1986837","article-title":"Pheochromocytoma with Acute Non-cardiac Pulmonary Edema: A Report of One Case and the Review of Literature","volume":"39","author":"Liu","year":"2021","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ecl.2025.02.006_bib57","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00007611-199307000-00023","article-title":"Pheochromocytoma manifested as noncardiogenic pulmonary edema","volume":"86","author":"Joshi","year":"1993","journal-title":"South Med J"},{"key":"10.1016\/j.ecl.2025.02.006_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/SMJ.0b013e318167ab4f","article-title":"Rhabdomyolysis and acute myoglobinuric renal failure in a patient with bilateral pheochromocytoma following open pyelolithotomy","volume":"101","author":"Anaforoglu","year":"2008","journal-title":"South Med J"},{"key":"10.1016\/j.ecl.2025.02.006_bib59","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.aje.a113947","article-title":"Biochemical screening for pheochromocytoma. Superiority of urinary metanephrines measurements","volume":"120","author":"Manu","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ecl.2025.02.006_bib60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/jc.2007-1354","article-title":"Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma","volume":"93","author":"Algeciras-Schimnich","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","author":"Yu","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ecl.2025.02.006_bib62","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1210\/jc.2012-2975","article-title":"Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators","volume":"98","author":"Gimenez-Roqueplo","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00188673","article-title":"Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities","volume":"21","author":"van Gils","year":"1994","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib64","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2025.02.006_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0749-0704(05)70150-0","article-title":"Hypothalamic-pituitary-adrenal insufficiency","volume":"17","author":"Zaloga","year":"2001","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.ecl.2025.02.006_bib66","first-page":"2909","article-title":"Clinical review 130: Addison\u2019s disease 2001","volume":"86","author":"Ten","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib67","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s40618-019-01079-6","article-title":"Epidemiology, pathogenesis, and diagnosis of Addison\u2019s disease in adults","volume":"42","author":"Betterle","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2025.02.006_bib68","article-title":"Ethnic and National Differences in Congenital Adrenal Hyperplasia Incidence: A Systematic Review and Meta-analysis","author":"Navarro-Zambrana","year":"2022","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ecl.2025.02.006_bib69","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency","volume":"3","author":"Bancos","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ecl.2025.02.006_bib70","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2025.02.006_bib71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib72","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jemermed.2022.06.005","article-title":"Diagnosis and Management of Adrenal Insufficiency and Adrenal Crisis in the Emergency Department","volume":"63","author":"Lentz","year":"2022","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-110-3-227","article-title":"Bilateral massive adrenal hemorrhage: early recognition and treatment","volume":"110","author":"Rao","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib74","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.02.006_bib75","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-14-0824","article-title":"Extensive expertise in endocrinology. Adrenal crisis","volume":"172","author":"Allolio","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2025.02.006_bib76","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/anae.14963","article-title":"Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK","volume":"75","author":"Woodcock","year":"2020","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ecl.2025.02.006_bib77","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.ecl.2025.02.006_bib79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4274\/jcrpe.galenos.2020.2020.0214","article-title":"Adrenoleukodystrophy in the Differential Diagnosis of Boys Presenting with Primary Adrenal Insufficiency without Adrenal Antibodies","volume":"13","author":"Ryalls","year":"2021","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.ecl.2025.02.006_bib80","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2025.02.006_bib81","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman","year":"2013","journal-title":"Arthritis Care Res"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:20:45Z","timestamp":1770412845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852925000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0889852925000088"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2025.02.006","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenal Emergencies","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2025.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}